AnalystsMatthew CaufieldMatthew Caufield's Stock Forecasts
AnalystsMatthew Caufield
Analyst Ranking
Top 21%
#1070 out of 5290 analysts
Average Return
+3.75%
Win Rate
39%71 out of 183
Risk vs Reward
Poor
Good
Matthew Caufield's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Opus Genetics IncIRD | +400.00% | $0.91 | $4.55 | 2025-04-01 - 2026-03-31 | Buy |
Opus Genetics IncIRD | +374.92% | $0.98 | $4.64 | 2025-06-27 - 2026-06-04 | Buy |
Phathom Pharmaceuticals IncPHAT | +335.14% | $2.76 | $12.01 | 2025-05-02 - 2026-05-01 | Buy |
Zenas Biopharma IncZBIO | +271.61% | $8.77 | $32.59 | 2024-12-16 - 2025-12-15 | Buy |
Surrozen IncSRZN | +266.00% | $8.00 | $29.28 | 2025-05-12 - 2026-05-11 | Buy |
Matthew Caufield Analyst Color
Get additional color on Matthew Caufield's coverage of popular stocks
Matthew Caufield's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Upstream Bio IncUPB | 1 | Buy | $36.00 | +384.52% | Initiates Coverage On | 2 days ago |
Zenas Biopharma IncZBIO | 7 | Buy | $44.00 | +139.39% | Reiterates | 21 days ago |
Lenz Therapeutics IncLENZ | 9 | Buy | $38.00 | +427.78% | Maintains | 24 days ago |
Surrozen IncSRZN | 5 | Buy | $44.00 | +80.48% | Maintains | a month ago |
Tarsus Pharmaceuticals IncTARS | 3 | Buy | $88.00 | +45.84% | Reiterates | a month ago |
Fibrobiologics IncFBLG | 10 | Buy | $8.00 | +647.66% | Maintains | 2 months ago |
Kodiak Sciences IncKOD | 10 | Buy | $58.00 | +69.79% | Reiterates | 2 months ago |
4d Molecular Therapeutics IncFDMT | 19 | Buy | $36.00 | +259.64% | Reiterates | 3 months ago |
Aldeyra Therapeutics IncALDX | 14 | Hold | $2.00 | +13.64% | Downgrades | 3 months ago |
Immunic IncIMUX | 8 | Buy | $50.00 | +246.50% | Maintains | 3 months ago |
Ardelyx IncARDX | 2 | Buy | $18.00 | +233.33% | Maintains | 4 months ago |
Akebia Therapeutics IncAKBA | 4 | Buy | $6.00 | +518.56% | Reiterates | 4 months ago |
Adverum Biotechnologies IncADVM | 8 | Hold | $5.00 | +14.68% | Downgrades | 7 months ago |
Mineralys Therapeutics IncMLYS | 13 | Buy | $56.00 | +123.55% | Maintains | 7 months ago |
Phathom Pharmaceuticals IncPHAT | 11 | Buy | $26.00 | +163.69% | Maintains | 7 months ago |
Diamedica Therapeutics IncDMAC | 7 | Buy | $12.00 | +105.48% | Reiterates | 10 months ago |
Lyra Therapeutics IncLYRA | 8 | Hold | $16.00 | +3,100.00% | Reiterates | 10 months ago |
Opus Genetics IncIRD | 13 | Buy | $8.00 | +72.41% | Reiterates | a year ago |
Unity Biotechnology IncUNBX | 9 | Hold | $2.00 | N/A | Downgrades | a year ago |
Optinose IncOPTN | 8 | Hold | $9.00 | N/A | Reiterates | a year ago |
Hillevax IncHLVX | 5 | Hold | $2.00 | N/A | Reiterates | a year ago |
Opthea LtdOPTEY | 7 | Hold | $2.00 | N/A | Downgrades | a year ago |
Hyperion Defi IncHYPD | 16 | Hold | $2.00 | N/A | Reiterates | a year ago |
FabrinetFN | 1 | Buy | $28.00 | N/A | Reiterates | 3 years ago |
Iveric Bio IncISEE | 6 | Hold | $40.00 | N/A | Downgrades | 3 years ago |
Oyster Point Pharma IncOYST | 1 | Buy | $20.00 | N/A | Initiates Coverage On | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.